IBDEI0XG ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16598,2)
 ;;=^37604
 ;;^UTILITY(U,$J,358.3,16599,0)
 ;;=788.1^^108^1046^36
 ;;^UTILITY(U,$J,358.3,16599,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16599,1,3,0)
 ;;=3^788.1
 ;;^UTILITY(U,$J,358.3,16599,1,4,0)
 ;;=4^Dysuria
 ;;^UTILITY(U,$J,358.3,16599,2)
 ;;=^37716
 ;;^UTILITY(U,$J,358.3,16600,0)
 ;;=789.30^^108^1046^70
 ;;^UTILITY(U,$J,358.3,16600,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16600,1,3,0)
 ;;=3^789.30
 ;;^UTILITY(U,$J,358.3,16600,1,4,0)
 ;;=4^Pelvic Abdominal Mass
 ;;^UTILITY(U,$J,358.3,16600,2)
 ;;=^917
 ;;^UTILITY(U,$J,358.3,16601,0)
 ;;=614.9^^108^1046^71
 ;;^UTILITY(U,$J,358.3,16601,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16601,1,3,0)
 ;;=3^614.9
 ;;^UTILITY(U,$J,358.3,16601,1,4,0)
 ;;=4^Pelvic Inflammatory Disease
 ;;^UTILITY(U,$J,358.3,16601,2)
 ;;=^3537
 ;;^UTILITY(U,$J,358.3,16602,0)
 ;;=218.9^^108^1046^93
 ;;^UTILITY(U,$J,358.3,16602,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16602,1,3,0)
 ;;=3^218.9
 ;;^UTILITY(U,$J,358.3,16602,1,4,0)
 ;;=4^Uterine Fibroids
 ;;^UTILITY(U,$J,358.3,16602,2)
 ;;=^68944
 ;;^UTILITY(U,$J,358.3,16603,0)
 ;;=618.1^^108^1046^94
 ;;^UTILITY(U,$J,358.3,16603,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16603,1,3,0)
 ;;=3^618.1
 ;;^UTILITY(U,$J,358.3,16603,1,4,0)
 ;;=4^Uterine Prolapse
 ;;^UTILITY(U,$J,358.3,16603,2)
 ;;=^124773
 ;;^UTILITY(U,$J,358.3,16604,0)
 ;;=112.1^^108^1046^96
 ;;^UTILITY(U,$J,358.3,16604,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16604,1,3,0)
 ;;=3^112.1
 ;;^UTILITY(U,$J,358.3,16604,1,4,0)
 ;;=4^Vaginitis, Candidal
 ;;^UTILITY(U,$J,358.3,16604,2)
 ;;=^18615
 ;;^UTILITY(U,$J,358.3,16605,0)
 ;;=099.53^^108^1046^99
 ;;^UTILITY(U,$J,358.3,16605,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16605,1,3,0)
 ;;=3^099.53
 ;;^UTILITY(U,$J,358.3,16605,1,4,0)
 ;;=4^Vaginits, Chlamydial
 ;;^UTILITY(U,$J,358.3,16605,2)
 ;;=^293988
 ;;^UTILITY(U,$J,358.3,16606,0)
 ;;=131.01^^108^1046^97
 ;;^UTILITY(U,$J,358.3,16606,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16606,1,3,0)
 ;;=3^131.01
 ;;^UTILITY(U,$J,358.3,16606,1,4,0)
 ;;=4^Vaginitis, Trichonomal
 ;;^UTILITY(U,$J,358.3,16606,2)
 ;;=^121763
 ;;^UTILITY(U,$J,358.3,16607,0)
 ;;=592.0^^108^1046^55
 ;;^UTILITY(U,$J,358.3,16607,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16607,1,3,0)
 ;;=3^592.0
 ;;^UTILITY(U,$J,358.3,16607,1,4,0)
 ;;=4^Kidney Stones
 ;;^UTILITY(U,$J,358.3,16607,2)
 ;;=^67056
 ;;^UTILITY(U,$J,358.3,16608,0)
 ;;=627.2^^108^1046^90
 ;;^UTILITY(U,$J,358.3,16608,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16608,1,3,0)
 ;;=3^627.2
 ;;^UTILITY(U,$J,358.3,16608,1,4,0)
 ;;=4^Symptomatic Menopause
 ;;^UTILITY(U,$J,358.3,16608,2)
 ;;=^328735
 ;;^UTILITY(U,$J,358.3,16609,0)
 ;;=622.10^^108^1046^33
 ;;^UTILITY(U,$J,358.3,16609,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16609,1,3,0)
 ;;=3^622.10
 ;;^UTILITY(U,$J,358.3,16609,1,4,0)
 ;;=4^Dysplasia of Cervix
 ;;^UTILITY(U,$J,358.3,16609,2)
 ;;=^331546
 ;;^UTILITY(U,$J,358.3,16610,0)
 ;;=622.11^^108^1046^34
 ;;^UTILITY(U,$J,358.3,16610,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16610,1,3,0)
 ;;=3^622.11
 ;;^UTILITY(U,$J,358.3,16610,1,4,0)
 ;;=4^Dysplasia of Cervix, Mild
 ;;^UTILITY(U,$J,358.3,16610,2)
 ;;=^331547
 ;;^UTILITY(U,$J,358.3,16611,0)
 ;;=622.12^^108^1046^35
 ;;^UTILITY(U,$J,358.3,16611,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16611,1,3,0)
 ;;=3^622.12
 ;;^UTILITY(U,$J,358.3,16611,1,4,0)
 ;;=4^Dysplasia of Cervix, Moderate
 ;;^UTILITY(U,$J,358.3,16611,2)
 ;;=^331548
 ;;^UTILITY(U,$J,358.3,16612,0)
 ;;=V72.40^^108^1046^77
 ;;^UTILITY(U,$J,358.3,16612,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16612,1,3,0)
 ;;=3^V72.40
